Sökning: WFRF:(Berlin Gösta)
> (2010-2014) >
Analyses of data of...
Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry
-
- Mörtzell, Monica (författare)
- Umeå universitet,Medicin,Umeå University,University Hospital Karolinska,University Hospital, Hradec Kralove,San Giovanni Calibita Fatebenefratelli Hospital
-
- Berlin, Gösta (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet,Klinisk immunologi och transfusionsmedicin
-
- Nilsson, T (författare)
- University of Uppsala Hospital
-
visa fler...
-
- Axelsson, C G (författare)
- University Hospital, Örebro,University Hospital, Vilnius
-
- Efvergren, M (författare)
- University Hospital Karolinska
-
- Audzijoni, J (författare)
- University Hospital, Vilnius
-
- Griskevicius, A (författare)
- University Hospital, Vilnius
-
- Ptak, J (författare)
- County Hospital, Czech Republic
-
- Blaha, M (författare)
- University Hospital, Hradec Kralove
-
- Tomsova, H (författare)
- University Hospital, Hradec Kralove
-
- M Liumbruno, G (författare)
- San Giovanni Calibita Fatebenefratelli Hospital
-
- Centoni, P (författare)
- University Hospital, Livorno
-
- Newman, E (författare)
- Concord Repatriat General Hospital
-
- Eloot, S (författare)
- Ghent University Hospital
-
- Dhondt, A (författare)
- Ghent University Hospital
-
- Tomaz, J (författare)
- University Hospital, Coimbra
-
- Witt, V (författare)
- University Hospital, Vienna
-
- Rock, G (författare)
- University Hospital, Ottawa
-
- Stegmayr, Bernd (författare)
- Umeå universitet,Medicin,Umeå University
-
visa färre...
-
(creator_code:org_t)
- Elsevier, 2011
- 2011
- Engelska.
-
Ingår i: Transfusion and apheresis science. - : Elsevier. - 1473-0502 .- 1878-1683. ; 45:2, s. 125-131
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Thrombotic Microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. less thanbrgreater than less thanbrgreater thanThe aim of this study was to investigate the outcome and prognostic variables of TMA-patients. less thanbrgreater than less thanbrgreater thanMaterials and methods: Data were consecutively retrieved from the WAA-apheresis registry (www.waa-registry.org) during 2003-2009. Included were all 120 patients (1237 procedures) who suffered from various forms of TMA, as registered by the ICD-10 code M31.1. Besides registry data, more extensive information was retrieved from the latest 64 patients. Adverse events of the TMA patients were compared to those of the other patients in the registry. less thanbrgreater than less thanbrgreater thanResults: The mean age was 46 years (range 11-85 years, 57% women). In 72% therapeutic apheresis was due to an acute indication while a long-term indication was present in 28%. Plasma exchange was performed by centrifugation and filtration technique (95% and 4%, respectively), and immunoadsorption in 1% of the patients. Only fresh frozen plasma was used as replacement fluid in 69% of procedures. Adverse events were more frequent than in the general apheresis population (10% versus 5%, RR 1.9, CI 1.6-2.3). No death occurred due to apheresis treatment. Three percent of the procedures were interrupted. Bronchospasm and/or anaphylactic shock were present in two patients and one patient suffered from TRALI. At admission 26% were bedridden and needed to be fed. The risk of dying during the treatment period was significantly higher if the patient also suffered from a compromising disease, such as cancer. There was an inverse correlation between the ADAMTS13 level and the antibody titer (r = -0.47, p = 0.034). less thanbrgreater than less thanbrgreater thanConclusions: Patients with TMA have an increased risk for moderate and severe AE compared to the general apheresis population. Many patients were severely ill at admission. The prognosis is worse if the patient also has a severe chronic disease. Even slightly increased ADAMTS13-antibody titers seem to have a negative impact on the ADAMTS13 levels. (C) 2011 Elsevier Ltd. All rights reserved.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- Thrombotic Microangiopathy
- Hemolytic uremic syndrome
- ADAMTS13
- Prognosis
- TMA
- TTP
- HUS
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Mörtzell, Monica
-
Berlin, Gösta
-
Nilsson, T
-
Axelsson, C G
-
Efvergren, M
-
Audzijoni, J
-
visa fler...
-
Griskevicius, A
-
Ptak, J
-
Blaha, M
-
Tomsova, H
-
M Liumbruno, G
-
Centoni, P
-
Newman, E
-
Eloot, S
-
Dhondt, A
-
Tomaz, J
-
Witt, V
-
Rock, G
-
Stegmayr, Bernd
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Transfusion and ...
- Av lärosätet
-
Linköpings universitet
-
Umeå universitet